在没有冠状动脉扩张的川崎病患者中,左心室亚临床功能障碍和心肌异常之间的关联
Lei Hu1,2, Ran Sun1,2, Zhongqin Zhou1,2
1Department of Radiology, West China Second University Hospital of Sichuan University, Chengdu, 610041, China.
Pediatric radiology
|June 18, 2025
概括
没有冠状动脉扩张的川崎病患者表现出亚临床心脏功能障碍. 由T1值变化表明的心肌异常,与这些患者的全球纵向应变减少有关.
科学领域:
- 心脏病学 心脏病学
- 儿童心脏病学 儿童心脏病学
- 医疗成像医学成像
背景情况:
- 亚临床心脏功能障碍与川崎病冠状动脉扩张有关.
- 在没有冠状动脉扩张的川崎病患者中,心脏功能和心肌特征尚未得到充分研究.
研究的目的:
- 在没有冠状动脉扩张的Kawasaki病患者中,使用心脏MRI评估心脏功能障碍和心肌组织特征.
- 研究亚临床功能障碍和心肌异常之间的关联.
主要方法:
- 追溯招募72名川崎病患者 (没有冠状动脉扩张) 和30名对照.
- 使用心脏MRI的组之间的菌株参数和映射值的比较.
- 全球纵向菌株和全球原生T1值的分析.
主要成果:
- 与对照组 (-15.1±4.2%) 相比,川崎病患者表现出较低的全球纵向菌株 (-13.2±3.9%).
- 全球原生T1值在Kawasaki病患者 (1306.5±75.2毫秒) 和对照组 (1264.3±65.5毫秒) 中较高.
- 全球原生T1值与全球纵向菌株相关 (r=0.22,P<0.01) 并独立相关 (β=0.11,P=0.01).
结论:
- 没有冠状动脉扩张的川崎病患者经历亚临床心脏功能障碍.
- 通过改变T1映射证明的心肌异常,与慢性阶段的纵向应变受损有关.
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
71
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
71
Mitral Stenosis II: Clinical features and Diagnostic Tests
39
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
39
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
59
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
59
Cardiomyopathy III: Hypertrophic Cardiomyopathy
65
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
65
Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30


